PureTech Health plc (OTCMKTS:PTCHF – Get Free Report) shares shot up 1.1% during trading on Monday . The company traded as high as $1.92 and last traded at $1.92. 40,000 shares were traded during mid-day trading, an increase of 19% from the average session volume of 33,720 shares. The stock had previously closed at $1.90.
PureTech Health Stock Performance
The firm’s 50 day moving average price is $1.98 and its two-hundred day moving average price is $2.35.
PureTech Health Company Profile
PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, which is under Phase 2 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, targeting galectin-9 for treating solid tumors and hematological malignancies.
Featured Articles
- Five stocks we like better than PureTech Health
- Comparing and Trading High PE Ratio Stocks
- Chinese Stocks Cool Off: Time to Buy the Dip in These 2 Stocks?
- Trading Halts Explained
- Goldman Sachs Highlights 3 Top Short Squeeze Stocks to Watch
- What Are Growth Stocks and Investing in Them
- Walmart is Up 56% YTD, Is it Still a Top Consumer Staples Stock?
Receive News & Ratings for PureTech Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PureTech Health and related companies with MarketBeat.com's FREE daily email newsletter.
